Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 7.7531 | 93 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 7.73757 | 92 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 7.74388 | 92 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 7.33239 | 90 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 7.70068 | 92 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 8.11674 | 95 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 7.84026 | 94 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 7.7233 | 93 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 7.64 | 92 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 7.70989 | 92 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 7.72241 | 93 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 7.77777 | 92 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 7.7331 | 92 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 7.7237 | 93 |